<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36264717</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>09</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2328-9503</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>11</Issue><PubDate><Year>2022</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Annals of clinical and translational neurology</Title><ISOAbbreviation>Ann Clin Transl Neurol</ISOAbbreviation></Journal><ArticleTitle>MicroRNA signatures in genetic frontotemporal dementia and amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>1778</StartPage><EndPage>1791</EndPage><MedlinePgn>1778-1791</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/acn3.51674</ELocationID><Abstract><AbstractText Label="OBJECTIVE">MicroRNAs are promising biomarkers of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), but discrepant results between studies have so far hampered their use in clinical trials. We aim to assess all previously identified circulating microRNA signatures as potential biomarkers of genetic FTD and/or ALS, using homogeneous, independent validation cohorts of C9orf72 and GRN mutation carriers.</AbstractText><AbstractText Label="METHODS">104 individuals carrying a C9orf72 or a GRN mutation, along with 31 controls, were recruited through the French research network on FTD/ALS. All subjects underwent blood sampling, from which circulating microRNAs were extracted. We measured differences in the expression levels of 65 microRNAs, selected from 15 published studies about FTD or ALS, between 31 controls, 17 C9orf72 presymptomatic subjects, and 29 C9orf72 patients. We also assessed differences in the expression levels of 30 microRNAs, selected from five studies about FTD, between 31 controls, 30 GRN presymptomatic subjects, and 28 GRN patients.</AbstractText><AbstractText Label="RESULTS">More than half (35/65) of the selected microRNAs were differentially expressed in the C9orf72 cohort, while only a small proportion (5/30) of microRNAs were differentially expressed in the GRN cohort. In multivariate analyses, only individuals in the C9orf72 cohort could be adequately classified (ROC AUC up to 0.98 for controls versus presymptomatic subjects, 0.94 for controls versus patients, and 0.77 for presymptomatic subjects versus patients) with some of the signatures.</AbstractText><AbstractText Label="INTERPRETATION">Our results suggest that previously identified microRNAs using sporadic or mixed cohorts of FTD and ALS patients could potentially serve as biomarkers of C9orf72-associated disease, but not GRN-associated disease.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kmetzsch</LastName><ForeName>Virgilio</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0003-3691-0180</Identifier><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Institut du Cerveau - Paris Brain Institute - ICM, CNRS, Inria, Inserm, AP-HP, H&#xf4;pital de la Piti&#xe9; Salp&#xea;tri&#xe8;re, F-75013, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Univ Rennes, Inria, CNRS, IRISA, F-35000, Rennes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Latouche</LastName><ForeName>Morwena</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Institut du Cerveau - Paris Brain Institute - ICM, CNRS, Inserm, AP-HP, H&#xf4;pital de la Piti&#xe9; Salp&#xea;tri&#xe8;re, F-75013, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saracino</LastName><ForeName>Dario</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Institut du Cerveau - Paris Brain Institute - ICM, CNRS, Inria, Inserm, AP-HP, H&#xf4;pital de la Piti&#xe9; Salp&#xea;tri&#xe8;re, F-75013, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre de r&#xe9;f&#xe9;rence des d&#xe9;mences rares ou pr&#xe9;coces, IM2A, D&#xe9;partement de Neurologie, AP-HP - H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>D&#xe9;partement de Neurologie, AP-HP - H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rinaldi</LastName><ForeName>Daisy</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Institut du Cerveau - Paris Brain Institute - ICM, CNRS, Inserm, AP-HP, H&#xf4;pital de la Piti&#xe9; Salp&#xea;tri&#xe8;re, F-75013, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre de r&#xe9;f&#xe9;rence des d&#xe9;mences rares ou pr&#xe9;coces, IM2A, D&#xe9;partement de Neurologie, AP-HP - H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>D&#xe9;partement de Neurologie, AP-HP - H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camuzat</LastName><ForeName>Agn&#xe8;s</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Institut du Cerveau - Paris Brain Institute - ICM, CNRS, Inserm, AP-HP, H&#xf4;pital de la Piti&#xe9; Salp&#xea;tri&#xe8;re, F-75013, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>EPHE, PSL Research University, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gareau</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Institut du Cerveau - Paris Brain Institute - ICM, CNRS, Inserm, AP-HP, H&#xf4;pital de la Piti&#xe9; Salp&#xea;tri&#xe8;re, F-75013, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>French Research Network on FTD/ALS</CollectiveName></Author><Author ValidYN="Y"><LastName>Le Ber</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Institut du Cerveau - Paris Brain Institute - ICM, CNRS, Inserm, AP-HP, H&#xf4;pital de la Piti&#xe9; Salp&#xea;tri&#xe8;re, F-75013, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre de r&#xe9;f&#xe9;rence des d&#xe9;mences rares ou pr&#xe9;coces, IM2A, D&#xe9;partement de Neurologie, AP-HP - H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>D&#xe9;partement de Neurologie, AP-HP - H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Paris Brain Institute - Institut du Cerveau - ICM, FrontLab, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colliot</LastName><ForeName>Olivier</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Institut du Cerveau - Paris Brain Institute - ICM, CNRS, Inria, Inserm, AP-HP, H&#xf4;pital de la Piti&#xe9; Salp&#xea;tri&#xe8;re, F-75013, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Becker</LastName><ForeName>Emmanuelle</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Univ Rennes, Inria, CNRS, IRISA, F-35000, Rennes, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Clin Transl Neurol</MedlineTA><NlmUniqueID>101623278</NlmUniqueID><ISSNLinking>2328-9503</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020774" MajorTopicYN="Y">Pick Disease of the Brain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>9</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>20</Day><Hour>13</Hour><Minute>32</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36264717</ArticleId><ArticleId IdType="pmc">PMC9639633</ArticleId><ArticleId IdType="doi">10.1002/acn3.51674</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Neary D, Snowden J, Mann D. Frontotemporal dementia. Lancet Neurol. 2005;4(11):771&#x2010;780. doi:10.1016/S1474-4422(05)70223-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(05)70223-4</ArticleId><ArticleId IdType="pubmed">16239184</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus HM, Mackenzie IR, Boeve BF, et&#xa0;al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p&#x2010;linked FTD and ALS. Neuron. 2011;72(2):245&#x2010;256. doi:10.1016/j.neuron.2011.09.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Majounie E, Waite A, et&#xa0;al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21&#x2010;linked ALS&#x2010;FTD. Neuron. 2011;72(2):257&#x2010;268. doi:10.1016/j.neuron.2011.09.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasinelli P, Brown RH. Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat Rev Neurosci. 2006;7(9):710&#x2010;723. doi:10.1038/nrn1971</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn1971</ArticleId><ArticleId IdType="pubmed">16924260</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohrer JD, Nicholas JM, Cash DM, et&#xa0;al. Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the genetic frontotemporal dementia initiative (GENFI) study: a cross&#x2010;sectional analysis. Lancet Neurol. 2015;14(3):253&#x2010;262. doi:10.1016/S1474-4422(14)70324-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(14)70324-2</ArticleId><ArticleId IdType="pmc">PMC6742501</ArticleId><ArticleId IdType="pubmed">25662776</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasso M, Piscopo P, Crestini A, Confaloni A, Denti MA. Circulating microRNAs in neurodegenerative diseases. In: Igaz P, ed. Circulating MicroRNAs in Disease Diagnostics and their Potential Biological Relevance. Experientia Supplementum. Springer; 2015:151&#x2010;169. doi:10.1007/978-3-0348-0955-9_7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-0348-0955-9_7</ArticleId><ArticleId IdType="pubmed">26608203</ArticleId></ArticleIdList></Reference><Reference><Citation>Huntzinger E, Izaurralde E. Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet. 2011;12(2):99&#x2010;110. doi:10.1038/nrg2936</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg2936</ArticleId><ArticleId IdType="pubmed">21245828</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasso M, Piscopo P, Talarico G, et&#xa0;al. Plasma microRNA profiling distinguishes patients with frontotemporal dementia from healthy subjects. Neurobiol Aging. 2019;84:240.e1&#x2010;240.e12. doi:10.1016/j.neurobiolaging.2019.01.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2019.01.024</ArticleId><ArticleId IdType="pubmed">30826067</ArticleId></ArticleIdList></Reference><Reference><Citation>Piscopo P, Grasso M, Puopolo M, et&#xa0;al. Circulating miR&#x2010;127&#x2010;3p as a potential biomarker for differential diagnosis in frontotemporal dementia. J Alzheimers Dis. 2018;65(2):455&#x2010;464. doi:10.3233/JAD-180364</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-180364</ArticleId><ArticleId IdType="pubmed">30056425</ArticleId></ArticleIdList></Reference><Reference><Citation>Denk J, Oberhauser F, Kornhuber J, et&#xa0;al. Specific serum and CSF microRNA profiles distinguish sporadic behavioural variant of frontotemporal dementia compared with Alzheimer patients and cognitively healthy controls. PloS One. 2018;13(5):e0197329. doi:10.1371/journal.pone.0197329</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0197329</ArticleId><ArticleId IdType="pmc">PMC5945001</ArticleId><ArticleId IdType="pubmed">29746584</ArticleId></ArticleIdList></Reference><Reference><Citation>Kmetzsch V, Anquetil V, Saracino D, et&#xa0;al. Plasma microRNA signature in presymptomatic and symptomatic subjects with C9orf72&#x2010;associated frontotemporal dementia and amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2021;92(5):485&#x2010;493. doi:10.1136/jnnp-2020-324647</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-324647</ArticleId><ArticleId IdType="pmc">PMC8053348</ArticleId><ArticleId IdType="pubmed">33239440</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheinerman KS, Toledo JB, Tsivinsky VG, et&#xa0;al. Circulating brain&#x2010;enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases. Alzheimers Res Ther. 2017;9(1):89. doi:10.1186/s13195-017-0316-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-017-0316-0</ArticleId><ArticleId IdType="pmc">PMC5679501</ArticleId><ArticleId IdType="pubmed">29121998</ArticleId></ArticleIdList></Reference><Reference><Citation>Magen I, Yacovzada NS, Yanowski E, et&#xa0;al. Circulating miR&#x2010;181 is a prognostic biomarker for amyotrophic lateral sclerosis. Nat Neurosci. 2021;24(11):1534&#x2010;1541. doi:10.1038/s41593-021-00936-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-021-00936-z</ArticleId><ArticleId IdType="pubmed">34711961</ArticleId></ArticleIdList></Reference><Reference><Citation>Soliman R, Mousa NO, Rashed HR, et&#xa0;al. Assessment of diagnostic potential of some circulating microRNAs in amyotrophic lateral sclerosis patients, an Egyptian study. Clin Neurol Neurosurg. 2021;208:106883. doi:10.1016/j.clineuro.2021.106883</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clineuro.2021.106883</ArticleId><ArticleId IdType="pubmed">34454204</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrowolny G, Martone J, Lepore E, et&#xa0;al. A longitudinal study defined circulating microRNAs as reliable biomarkers for disease prognosis and progression in ALS human patients. Cell Death Discov. 2021;7:4. doi:10.1038/s41420-020-00397-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41420-020-00397-6</ArticleId><ArticleId IdType="pmc">PMC7801652</ArticleId><ArticleId IdType="pubmed">33431881</ArticleId></ArticleIdList></Reference><Reference><Citation>Raheja R, Regev K, Healy BC, et&#xa0;al. Correlating serum microRNAs and clinical parameters in amyotrophic lateral sclerosis. Muscle Nerve. 2018;58(2):261&#x2010;269. doi:10.1002/mus.26106</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26106</ArticleId><ArticleId IdType="pmc">PMC6103911</ArticleId><ArticleId IdType="pubmed">29466830</ArticleId></ArticleIdList></Reference><Reference><Citation>Waller R, Goodall EF, Milo M, et&#xa0;al. Serum miRNAs miR&#x2010;206, 143&#x2010;3p and 374b&#x2010;5p as potential biomarkers for amyotrophic lateral sclerosis (ALS). Neurobiol Aging.&#xa0;2017;55:123&#x2010;131. doi:10.1016/j.neurobiolaging.2017.03.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.03.027</ArticleId><ArticleId IdType="pmc">PMC5455071</ArticleId><ArticleId IdType="pubmed">28454844</ArticleId></ArticleIdList></Reference><Reference><Citation>Tasca E, Pegoraro V, Merico A, Angelini C. Circulating microRNAs as biomarkers of muscle differentiation and atrophy in ALS. Clin Neuropathol. 2016;35(1):22&#x2010;30. doi:10.5414/NP300889</Citation><ArticleIdList><ArticleId IdType="doi">10.5414/NP300889</ArticleId><ArticleId IdType="pubmed">26588026</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi I, Hama Y, Matsushima M, et&#xa0;al. Identification of plasma microRNAs as a biomarker of sporadic amyotrophic lateral sclerosis. Mol Brain. 2015;8(1):67. doi:10.1186/s13041-015-0161-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-015-0161-7</ArticleId><ArticleId IdType="pmc">PMC4619470</ArticleId><ArticleId IdType="pubmed">26497046</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A, M&#xfc;ller K, Zondler L, et&#xa0;al. Serum microRNAs in sporadic amyotrophic lateral sclerosis. Neurobiol Aging. 2015;36(9):2660.e15&#x2010;2660.e20. doi:10.1016/j.neurobiolaging.2015.06.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.06.003</ArticleId><ArticleId IdType="pubmed">26142125</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A, M&#xfc;ller K, Zondler L, et&#xa0;al. Serum microRNAs in patients with genetic amyotrophic lateral sclerosis and pre&#x2010;manifest mutation carriers. Brain J Neurol. 2014;137(Pt 11):2938&#x2010;2950. doi:10.1093/brain/awu249</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu249</ArticleId><ArticleId IdType="pubmed">25193138</ArticleId></ArticleIdList></Reference><Reference><Citation>De Felice B, Annunziata A, Fiorentino G, et&#xa0;al. miR&#x2010;338&#x2010;3p is over&#x2010;expressed in blood, CFS, serum and spinal cord from sporadic amyotrophic lateral sclerosis patients. Neurogenetics. 2014;15(4):243&#x2010;253. doi:10.1007/s10048-014-0420-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10048-014-0420-2</ArticleId><ArticleId IdType="pubmed">25130371</ArticleId></ArticleIdList></Reference><Reference><Citation>Simr&#xe9;n J, Gustafson DR. A blood&#x2010;based biomarker of cognitive decline and interaction with lifestyle. JAMA Netw Open. 2022;5(3):e223602. doi:10.1001/jamanetworkopen.2022.3602</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.3602</ArticleId><ArticleId IdType="pubmed">35315922</ArticleId></ArticleIdList></Reference><Reference><Citation>Henriksen K, O'Bryant SE, Hampel H, et&#xa0;al. The future of blood&#x2010;based biomarkers for Alzheimer's disease. Alzheimers Dement J Alzheimers Assoc. 2014;10(1):115&#x2010;131. doi:10.1016/j.jalz.2013.01.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2013.01.013</ArticleId><ArticleId IdType="pmc">PMC4128378</ArticleId><ArticleId IdType="pubmed">23850333</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandrekar JN. Receiver operating characteristic curve in diagnostic test assessment. J Thorac Oncol. 2010;5(9):1315&#x2010;1316. doi:10.1097/JTO.0b013e3181ec173d</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JTO.0b013e3181ec173d</ArticleId><ArticleId IdType="pubmed">20736804</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Ber I, Guedj E, Gabelle A, et&#xa0;al. Demographic, neurological and behavioural characteristics and brain perfusion SPECT in frontal variant of frontotemporal dementia. Brain J Neurol. 2006;129(Pt 11):3051&#x2010;3065. doi:10.1093/brain/awl288</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awl288</ArticleId><ArticleId IdType="pubmed">17071924</ArticleId></ArticleIdList></Reference><Reference><Citation>Potla P, Ali SA, Kapoor M. A bioinformatics approach to microRNA&#x2010;sequencing analysis. Osteoarthr Cartil Open. 2021;3(1):100131. doi:10.1016/j.ocarto.2020.100131</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ocarto.2020.100131</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith T, Heger A, Sudbery I. UMI&#x2010;tools: modeling sequencing errors in unique molecular identifiers to improve quantification accuracy. Genome Res. 2017;27(3):491&#x2010;499. doi:10.1101/gr.209601.116</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.209601.116</ArticleId><ArticleId IdType="pmc">PMC5340976</ArticleId><ArticleId IdType="pubmed">28100584</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin M. Cutadapt removes adapter sequences from high&#x2010;throughput sequencing reads. EMBnetjournal. 2011;17(1):10&#x2010;12. doi:10.14806/ej.17.1.200</Citation><ArticleIdList><ArticleId IdType="doi">10.14806/ej.17.1.200</ArticleId></ArticleIdList></Reference><Reference><Citation>Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory&#x2010;efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009;10(3):R25. doi:10.1186/gb-2009-10-3-r25</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2009-10-3-r25</ArticleId><ArticleId IdType="pmc">PMC2690996</ArticleId><ArticleId IdType="pubmed">19261174</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Handsaker B, Wysoker A, et&#xa0;al. The sequence alignment/map format and SAMtools. Bioinforma Oxf Engl. 2009;25(16):2078&#x2010;2079. doi:10.1093/bioinformatics/btp352</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp352</ArticleId><ArticleId IdType="pmc">PMC2723002</ArticleId><ArticleId IdType="pubmed">19505943</ArticleId></ArticleIdList></Reference><Reference><Citation>Brennan S, Keon M, Liu B, Su Z, Saksena NK. Panoramic visualization of circulating MicroRNAs across neurodegenerative diseases in humans. Mol Neurobiol. 2019;56(11):7380&#x2010;7407. doi:10.1007/s12035-019-1615-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-019-1615-1</ArticleId><ArticleId IdType="pmc">PMC6815273</ArticleId><ArticleId IdType="pubmed">31037649</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A, Goswami A, Limm K, et&#xa0;al. A serum microRNA sequence reveals fragile X protein pathology in amyotrophic lateral sclerosis. Brain. 2021;144(4):1214&#x2010;1229. doi:10.1093/brain/awab018</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab018</ArticleId><ArticleId IdType="pmc">PMC8105042</ArticleId><ArticleId IdType="pubmed">33871026</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Q, Zhao Y, Zhou X, Luan J, Cui Y, Han J. Comparison of the extraction and determination of serum exosome and miRNA in serum and the detection of miR&#x2010;27a&#x2010;3p in serum exosome of ALS patients. Intractable Rare Dis Res. 2018;7(1):13&#x2010;18. doi:10.5582/irdr.2017.01091</Citation><ArticleIdList><ArticleId IdType="doi">10.5582/irdr.2017.01091</ArticleId><ArticleId IdType="pmc">PMC5849619</ArticleId><ArticleId IdType="pubmed">29552440</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinforma Oxf Engl. 2010;26(1):139&#x2010;140. doi:10.1093/bioinformatics/btp616</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp616</ArticleId><ArticleId IdType="pmc">PMC2796818</ArticleId><ArticleId IdType="pubmed">19910308</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson MD, Oshlack A. A scaling normalization method for differential expression analysis of RNA&#x2010;seq data. Genome Biol. 2010;11(3):R25. doi:10.1186/gb-2010-11-3-r25</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2010-11-3-r25</ArticleId><ArticleId IdType="pmc">PMC2864565</ArticleId><ArticleId IdType="pubmed">20196867</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol. 1995;57(1):289&#x2010;300.</Citation></Reference><Reference><Citation>Pedregosa F, Varoquaux G, Gramfort A, et&#xa0;al. Scikit&#x2010;learn: machine learning in python. J Mach Learn Res. 2011;12(Oct):2825&#x2010;2830.</Citation></Reference><Reference><Citation>Bengio Y, Grandvalet Y. No unbiased estimator of the variance of K&#x2010;fold cross&#x2010;validation. J Mach Learn Res. 2004;5(Sep):1089&#x2010;1105.</Citation></Reference><Reference><Citation>Toivonen JM, Manzano R, Oliv&#xe1;n S, Zaragoza P, Garc&#xed;a&#x2010;Redondo A, Osta R. MicroRNA&#x2010;206: a potential circulating biomarker candidate for amyotrophic lateral sclerosis. PLoS One. 2014;9(2):e89065. doi:10.1371/journal.pone.0089065</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0089065</ArticleId><ArticleId IdType="pmc">PMC3930686</ArticleId><ArticleId IdType="pubmed">24586506</ArticleId></ArticleIdList></Reference><Reference><Citation>Nosek BA, Ebersole CR, DeHaven AC, Mellor DT. The preregistration revolution. Proc Natl Acad Sci USA. 2018;115(11):2600&#x2010;2606. doi:10.1073/pnas.1708274114</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1708274114</ArticleId><ArticleId IdType="pmc">PMC5856500</ArticleId><ArticleId IdType="pubmed">29531091</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertrand A, Wen J, Rinaldi D, et&#xa0;al. Early cognitive, structural, and microstructural changes in Presymptomatic C9orf72 carriers younger than 40&#x2009;years. JAMA Neurol. 2018;75(2):236&#x2010;245. doi:10.1001/jamaneurol.2017.4266</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2017.4266</ArticleId><ArticleId IdType="pmc">PMC5838615</ArticleId><ArticleId IdType="pubmed">29197216</ArticleId></ArticleIdList></Reference><Reference><Citation>Saracino D, Dorgham K, Camuzat A, et&#xa0;al. Plasma NfL levels and longitudinal change rates in C9orf72 and GRN&#x2010;associated diseases: from tailored references to clinical applications. J Neurol Neurosurg Psychiatry. 2021;92(12):1278&#x2010;1288. doi:10.1136/jnnp-2021-326914</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2021-326914</ArticleId><ArticleId IdType="pmc">PMC8606463</ArticleId><ArticleId IdType="pubmed">34349004</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>